I do understand why they would use 6:1, however when it comes to the revenue we make, 12:1 is spot on, hence why I would definitely prefer the company to report their production on a 12:1 basis, so we can translate production directly to revenue.
Just my point of view anyway.
- Forums
- ASX - By Stock
- FFM
- Ann: Quarterly Update and Appendix 5B
Ann: Quarterly Update and Appendix 5B , page-11
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFM (ASX) to my watchlist
|
|||||
Last
84.0¢ |
Change
0.020(2.44%) |
Mkt cap ! $386.9M |
Open | High | Low | Value | Volume |
80.5¢ | 84.0¢ | 80.5¢ | $694.8K | 850.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 55084 | 83.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
84.0¢ | 22584 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 91864 | 0.820 |
7 | 54821 | 0.815 |
12 | 83588 | 0.810 |
9 | 101564 | 0.805 |
11 | 107103 | 0.800 |
Price($) | Vol. | No. |
---|---|---|
0.825 | 44241 | 9 |
0.830 | 92356 | 9 |
0.835 | 91133 | 10 |
0.840 | 32084 | 6 |
0.845 | 55588 | 6 |
Last trade - 12.25pm 16/07/2024 (20 minute delay) ? |
Featured News
FFM (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, CEO / Non-Exec Director
James Graham / Dr Alan Dunton
CEO / Non-Exec Director
SPONSORED BY The Market Online